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Endotoxemia is a leading cause of death in horses. If endotoxemia can be 
detected in a simple manner in colic horses, it would be helpful for selecting 
treatments and judging prognosis of affected horses. The purpose of the present 
study was to investigate the relationship among the lipopolysaccharide (LPS) 
concentration, certain liver functions, and prognosis of colic cases in horses. 
A chromogenic Limulus amebocyte lysate (LAL) assay was applied for the 
determination of endotoxin in equine plasma, and its sensitivity and reproducibility 
were evaluated. A highly significant linear relationship with a correlation 
coefficient of greater than 0.90 was observed in both the pyrogen-free water and 
absorbed equine plasma endotoxin standards between LPS concentrations in logio 
and OD405read at 40 and 45 minutes of incubation time. The recovery rates of LPS 
in equine plasma were from 84.146 % to 136.395 % with overall 107.786 ± 
24.340 % based on the OD values of the LPS amounts in pyrogen-free water as 
100 %. Despite the efforts to reduce interfering factors in plasma by the dilution­
Redacted for Privacyheating treatment, greater nonspecific reaction(s) were observed in the absorbed 
equine plasma endotoxin standard compared to the pyrogen-free water endotoxin 
standard. The precision of endotoxin standards (CV) between pyrogen-free water 
and absorbed equine plasma were between 19.427 % and 34.007 % at various LPS 
concentrations. 
The CV for intra-assay precisions among four different plasmas were 
between 4.225 % and 10.436 %, and the recovery rates were constant with overall 
100.196 ± 8.916 % based on the OD values of the LPS amounts in an arbitrary 
selected plasma as 100 %. Also, the CV for inter-assay precision repeatedly 
measured on 6 different plates on different days was 15.056 %. The limit of 
sensitivity in plasma was 6.25 pg/ml. 
It was found that the chromogenic LAL assay was unreliable when the 
pyrogen-free water was used to make endotoxin standard solutions. It was an 
essential to use the absorbed equine plasma to make endotoxin standard solutions 
that has been treated by the same pretreatment procedure as for the samples. 
Thirty-two horses with colic were assayed for plasma LPS concentration, 
the level of serum bile acids and serum y-glutamyl-transpeptidase (y-GT) activity. 
The results were analyzed for their relationship among them, and evaluated for 
their predictable values for the prognosis of colic cases. 
All measurements were made at the time of admission when horses were 
referred to the OSU veterinary teaching hospital with symptoms of colic. The 
horses were categorized into two groups based on the prognosis; survival or 
nonsurvival (death or euthanasia) group. Another two groups were categorized based on the plasma LPS concentrations in which horses with greater than the limit 
of sensitivity in the chromogenic LAL assay was allocated to the LPS-positive and 
those with less than that to the LPS-negative group. 
Of 32 cases, LPS was detected in the plasma of only 6 horses; 4 in the 
survival (n=15) and 2 in the nonsurvival (n=17) group. Nine horses had ischemic 
intestine; however only one of these had LPS detected in the plasma (7.635 pg/ml). 
There were no significant differences in serum bile acids and y-GT 
concentrations between survival and nonsurvival (P = 0.137, and 0.244, 
respectively), nor were there any differences in serum bile acids and y-GT 
concentrations between LPS-positive and LPS-negative groups (P = 0.281, and 
0.377, respectively). 
No single parameters including plasma LPS, serum bile acids, and y-GT 
concentrations were useful for the determination of prognosis of equine colic and 
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Literature Review
 2 
Colic in Horses 
Colic, or acute abdominal pain, is defined as the manifestation of visceral 
abdominal pain. It is a collective term for clinical signs of acute, chronic, or 
recurrent symptoms of pain resulting from potentially life-threatening diseases of 
the gastrointestinal tract of horses. 
There are several anatomic predisposing factors for horses to cause colic 
including: (1) horses cannot vomit because the distal portion of the esophagus is 
composed of smooth muscles and the horse has a well developed lower esophageal 
sphincter; (2) the intestines are prone to dislocate their physiological positions 
because of the unfixed position of the left colon and long mesentery of small 
intestine; and (3) the intestines, especially the large intestines, are easily impacted 
by the ingesta due to the upward movement of the ingesta and narrowing of the 
intestinal lumen at the pelvic flexure, and the termination of the right dorsal colon 
into the much narrower small colon.  Also, unlike other species, it is considered 
that the horse has a low threshold to pain.2 
There are numerous causes of colic including intestinal and non-intestinal 
disorders (Table 1, 2).2 3 
Table 1 Intestinal causes of colic in horses 
Common causes: 
accumulation of intestinal, cecal, or colonic gas 
hyper-mobility and intestinal spasms 
feed impaction, constipation 
'newborn meconium impaction 
foal gastric ulcers 
Less common causes: 
thromboembolism 
intestinal foreign body i.e., sand, enterolith, phytobezoar 
volvulus of small intestine 
pedunculated lipoma with bowel strangulation 
'hernia, inguinal, epiploic, umbilical, diaphragmatic 
nephrosplenic ligament bowel entrapment 
ascarid impaction 
'massive strongyle infection 
gastric dilation 
anterior enteritis or duodenitis-proximal jejunitis 
enteritis, impeding or acute 
peritonitis 
parasympathomimetic drugs
 
irritant cathartics
 
necrotizing enterocolitis or colitis X
 
psychogenic colic
 
rectal tear
 
volvulus or displacement of bowel
 
'rupture of stomach or intestine
 
ileus
 
intussusception
 
Uncommon causes 
abdominal adhesion 
intramural hematomas of stomach or intestine 
stenosis or stricture of bowel lumen 
'botulism 
'Potomac Horse Fever 
'exhaustion 
anaphylaxis 
Rhodococcus equi (Corynebacterium) gut abscess 
'cribbing or wind sucking 4 
Table 1 (continued) 
' abdominal fibroma 
'segmental ischemic necrosis following mesocolic tearing 
'Equine viral arthritis 
'anthrax with bleeding 
'malignant edema by Chrostridium spp. 
'malignant mesothelioma 
'gastric or intestinal tumor 
'atropine administration 
'vitamin K3 deficiency (mold sweet clover) 
Toxins 
cantharidin toxicity 
' dioxin 
' trichroloethylene-extracted feed toxicity 
'warfarin (dicumarol) 
'herbicides 
'lead poisoning 
nitrophenyl urea 
phenylbutazone or other NSAIDS 
' poison plants 
Table 2 Non-intestinal causes of colic in horses 
Common causes: 
' mesenteric abscess 
'ovarian tumor, abscess, or hematoma 
'parturition 
acute hepatitis, or hepatic lipidosis 
'diaphragmatic hernia 
'foal ruptured bladder 
'uterine torsion 
Less common causes: 
'urinary tract or renal disease, including urolithiasis 
pleuritis or pericarditis 
'retained placenta 
'uterine rupture or retroflexion 5 
Table 2 (continued) 
Uncommon causes: 
perirectal abscess 
pheochromocytoma 
purpura hemorrhagica 
biliary atresia 
vaginal or vulvar tear 
cholelithiasis 
white muscle disease 
rabies 
rupture of prepubic tendon 
splenitis, splenic abscess, splenomegaly 
cauda equina neuritis with retention of feces or urine 
Prognosis of equine colic depends on various conditions and lesions. In 
1986, White, et al examined a total of 4,644 cases of equine colic seen at 16 
veterinary teaching hospitals in the United States and England from the years 1979 
to 1984, and found that overall 59.8% out of 4,644 cases survived, 2,055 cases of 
them were going for surgery for colic with a 52.0% mortality.' A greater chance 
of survival was observed with simple obstruction cases than strangulating 
obstructions. Small intestinal diseases produced higher mortality rates than those of 
large intestinal diseases except for large colon torsion. 
There is no difference among different breeds in colic susceptibility. 
Though there is some variation, equine colic appears equally distributed throughout 
all ages.4-5 However, small intestinal volvulus and jejunal and ileal 
intussusceptions have been observed more frequently in younger horses (under 
three years of age), whereas small intestinal incarcerations in the epiploic foramen 6 
or by a pedunculated lipoma, large colon torsion, enteroliths and cecal impactions 
are reported to affect older horses (more than eight years of age).6' 7 
Numerous studies have evaluated usefulness of various physical and 
laboratory parameters for determining the prognosis for survival in colic horses. 
For example, the following parameters have been evaluated in the past: pulse rate,8' 
9, 10  packed cell volume,8' 9  oral mucosal capillary refill time,9 blood pressure,9 
anion gap
,11, 19, 20 degree of the pain, 
10, 14  serum lactate,9' 
12, 20  serum alkaline 
phosphatase,13' 14  lactate level in peritoneal fluids,9 hemostatic abnormalities 
including fibrin/fibrinogen degradation product (FDP) concentration's' 16, 17  and/or 
multi-variable prediction model." Although a specific diagnosis is useful for 
generating a list of treatment options, there has been no perfect prognosis 
parameter of equine colic so far. 
The worst scenario in equine colic is the destruction of the mucosal barrier 
in which the bowel is necrotized or the mucosal barrier is severely damaged due to 
compromising the vascular supply by strangulated, displaced, or infarcted bowels. 
This causes the intestinal bacteria to enter the systemic circulation, causing various 
serious conditions known as cardiovascular shock syndrome or endotoxemia 
triggered by endotoxin of gram-negative bacteria. The viability of intestine will be 
easily destroyed and becomes completely necrotic within four to five hours in the 
small intestine' 22 and large intestine22 by experimentally induced complete 
ischemia. 7 
Bacterial Lipopolysaccharide (LPS) 
The bacterial lipopolysaccharide or LPS is an amphipathic molecule and 
located exclusively in the outer membrane of gram-negative bacteria and is released 
after bacterial death or during bacterial proliferation.23 While the terms endotoxin 
and LPS are used interchangeably, the former term emphasizes the biological 
activity and the latter term refers particularly to the chemical structure and 
composition of the molecule, so it should be noted that not all bacterial LPS are 
endotoxin, and vice versa.23' 24, 25  The LPS molecules are large molecules whose 
molecular weight is 200,000 to 1,000,000 dalton and heat-stable (up to 100C). 
The structure of the LPS can be divided into two major regions (Fig. 1). 
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Fig. 1 Schematic structure of Salmonella lipopolysaccharide. 
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One is the polysaccharide region which is the hydrophilic portion and the 
other is hydrophobic portion called lipid A. The polysaccharide region is projected 
into the aqueous extracellular environment and is further subdivided into the 0 
antigen and core regions. The 0 antigen is linked covalently to the core region. 
The 0 antigen consists of repeating oligosaccharide with a branched 
oligosaccharide and is the immunodominant region of the LPS molecule in which it 
is highly variable and antigenically specific for each bacterial strain. Many types of 
sugars have been found as constituents of repeating units including natural sugars 
with 5 to 7 carbon atoms, deoxy and amino sugars, uronic and aminuronic acids, 
0-methyl, 0-acetyl, and phosphate-substituted sugars.26' 27 This diversity of the 
constituents and different types of linkage contributes to the immune diversity of 
the 0 antigen region. 
The core region consists of a branched hetero-oligosaccharide. In 
Enterobacteriaceae at least six individual core types have been described which 
show only minor differences in their compositions. The core region expresses 
much less diversity than the 0 antigen region.26 In general, there are two core 
regions that are recognized, the inner core and the outer core. The inner core is 
made by oligosaccharides of 3-deoxy-D-manno-2-octulosonic acid (KDO) and L­
glycero-D-mannoheptose, whereas the outer core region is composed of D-glucose, 
D-galactose and often N-acetyl-D-glucosamine. 26' 27 
The lipid A region, in turn linked covalently to the core region, possesses 
most of the toxic and biological properties of endotoxin. For example, endotoxin 9 
triggers the lethal toxicity, pyrogenecity, Swartzman reaction, complement 
activation, platelet aggregation, Hageman factor activation and release of an array 
of cytokines from macrophages and monocytes, all of which contribute to 
characteristic biological aspects of endotoxemia, and nearly all of them are 
mediated through the lipid A region. Also, it is this lipid A region that is reactive 
with the Limulus amebocyte lysate (LAL) assay, the rabbit pyrogen assay, and 
other bioassays.28' 29 The lipid A region constitutes the hydrophobic portion of the 
molecule that is largely buried into the bacterial outer membrane. The structure of 
the lipid A region is remarkably conserved within the Enterobacteriaceae and the 
characteristic and common to them is the presence of a bisphosphorylated 13 (1 -6)­
linked D-glucosamine compounds (phosphorylated glucosamine disaccharide) 
which is termed as the lipid A backbone. The lipid A backbone generally carries 
approximately four moles equivalents of (R)-3-hydroxy fatty acids (carbon numbers 
10 to 18), two of which coontain amino groups, and two others linked to backbone 
hydroxyl groups (Fig. 2). 10 
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Fig. 2 Chemical structure of KDO and lipid A in Escherichia Co li 
lipopolysaccharide. 
Endotoxemia in Horses with Colic 
The large intestine is heavily populated with obligate anaerobic and 
facultative enteric bacteria and the concentration of endotoxin in the large intestine 
is characteristically higher than that in the small intestine. As much as 80 itg of 
endotoxin/ml has been measured in the physiological status of the cecal lumen of 
the horses.''' Endotoxemia is the presence of endotoxin in the blood, however 11 
when this term is described clinically, it additionally implies the presence of 
clinical signs due to circulating endotoxin. Endotoxemia is known as the leading 
cause of death in horses,31 being closely involved in the pathogenesis of 
gastrointestinal disorders that cause colic in adult horses and septicemia of neonatal 
foals less than seven days of age.32 Horses are very sensitive to endotoxin and 
even small circulating quantities can induce profound cardiopulmonary 
alterations.31' 33 The mucosal barrier of the intestine which is composed of 
epithelial cells and the tight junctions between them and the lamina propria 
efficiently restricts the transmural movement of endotoxin and bacteria. Although 
the intestinal mucosa provides a highly efficient barrier-limiting transmural 
movement of endotoxin, small quantities of endotoxin are absorbed into the portal 
blood either by passive diffusion or by some active transport mechanism.34 These 
endotoxins are removed primarily by the monocyte phagocytic system of the liver 
or hepatic Kupffer cells and do not reach the peripheral blood in normal 
circumstances.35' 36 Significantly greater quantities of endotoxin escape the bowel 
and may reach the blood when the mucosal barrier is disrupted by intestinal 
ischemia (e.g., bowel torsion, infections, incarcerations), trauma (e.g., rectal 
perforation, ulcers), ionizing radiation, bacterial overgrowth, reduced intraluminal 
pH (e.g., grain overload), or inflammatory bowel disease (e.g., proximal enteritis, 
Potomac Horse Fever).37 These conditions not only overwhelm the capacity of the 
liver to remove endotoxin from the portal circulation, but also allow transmural 
movement of endotoxin into peritoneal cavity from which they reach the peripheral 12 
blood and lead to endotoxemia.38' 39' 40 Although not studied in horses, lymphatic 
circulation of the thoracic duct is an important liver-bypassing route for endotoxin 
from the peritoneal cavity and bowel to the systemic circulation in other species.41' 
42, 43 
After endotoxin accesses to the systemic circulation, the presence of 
endotoxin in the blood stream simultaneously initiates numerous and extremely 
complex processes of cellular interactions and clinical signs. The hemodynamic 
alterations occurring in endotoxemia represent the complex interrelationship 
between endotoxin-induced peripheral vasodilation and pulmonary 
vasoconstriction, with compensatory mechanisms that involve the heart and the 
central nervous system.'" The degree of cardiovascular system dysfunction is 
determined by the severity and the development of endotoxemia. Research in 
horses which were given various doses of endotoxin by several routes of 
administration shows that endotoxin causes early systemic vasoconstriction, 
tachycardia, arterial hypoxemia, tachypnea, and pulmonary hypertension followed 
by systemic hypotension and increased vascular permeability, Disseminated 
Intravascular Coagulopathy (DIC), and finally death. 31, 45, 46, 47, 48, 49 Endotoxemia 
profoundly disturbs the balance of homeostatic vascular integrity and tissue 
perfusion, which are maintained by complexes of vasodilators/vasoconstrictors, 
procoagulants/antiprocoagulants, proteases/antiproteases, and 
oxidants/antioxidants. This disturbance depends upon the stages and severities of 
endotoxemia and can be divided into two phases of it by experimentally induced 13 
endotoxemia.5° In the early phase of endotoxemia or pre-cytokine phase of 
endotoxemia, the vasoconstrictive effect of Thromboxane A2 (TXA2) is 
predominant, whereas in the late phase or post-cytokine phase of endotoxemia, 
there is widespread vasodilation in response to cytokine-induced mediators such as 
prostacyclin (PGI2) and nitric oxide.51 It is experimentally possible to minimize the 
development of the endotoxemia by the several cyclooxygenase inhibitors by which 
the plasma TXA2, as indicated by TXB2 and prostacyclin, as indicated by 6-keto­
prostaglandin Fic, concentrations were significantly decreased.52' 53' 
54, 55, 56, 57 
The first phase of endotoxemia is the pre-cytokine phase in which LPS can 
be neutralized by anti-LPS antibodies. However, most of the endotoxin binds to 
LPS-binding protein (LBP), a 58 kd glycoprotein synthesized in the liver.58 The 
endotoxin-LBP complexes, in turn, bind with CD14 which has high affinity for the 
specific cell surface receptor on macrophages and, to a lesser extent, monocytes.59 
This binding stimulates macrophages to process plasma membrane arachidonic 
acids into TXA2 and other vasoconstrictive mediators such as serotonin. This effect 
is especially pronounced in pulmonary circulation because of the presence of 
pulmonary intravascular macrophages and is evident clinically as tachypnea, and 
arterial hypoxia. It is likely this early vasoconstriction is also a feature of many 
cases of laminitis in endotoxemic horses. 
The second phase of endotoxemia is the post-cytokine phase. After the pre­
cytokine phase of endotoxemia in experimental models, the cytokines are produced. 
The mechanism considers that the binding of endotoxin-LBP complexes on 14 
macrophages initiates a series of intracellular events of transduction in which the 
activation of protein kinase C induces the production of the cytokines 60 Of 
particular importance are Tumor Necrosis Factor a (TNF-a) and Interluikine-1 
(IL-1). These cytokines act in autocrine and paracrine fashions via specific cell 
surface receptors on macrophages and other cells to boost their own secretion and 
to induce the production of several other cytokines which are important in the 
pathogenesis of endotoxemia.61 The second wave of inflammatory cytokines 
including Granulocytes-Monocytes Colony Stimulating Factor (GM-CSF), 
Interluikine-8 (IL-8), and Interluikine-6 (IL-6) are induced by TNF-a and IL-1.IL­
8 is a chemoattractant for neutrophils and may accelerate production and release of 
neutrophils from the bone marrow in concert with GM-CSF. 
TNF-a and IL-1 also act on neutrophils and endothelial cells to cause them 
to express adhesion molecules, which are a family of cell-surface glycoproteins 
including intercellular adhesion molecules, endothelial and leukocyte selectins and 
neutrophil integrins, and followed by margination of neutrophils onto the vascular 
endothelium. This margination accounts for the neutropenia found in most horses 
with endotoxemia. In response to TNF-a and IL-1, neutrophils become activated 
after attachment to endothelial cells, the importance of which is the activation of 
neutrophil phospholipase A2 (PLA2) which catalyzes luekotrien B4 (LTB4), which 
induces vasoconstriction and promotes chemotaxis62' 63 and Platelet Activating 
Factor (PAF).62 PAF is a vasoactive amine and is released from endotoxin­
stimulated granulocyte and macrophage and augments the numerous contribution of 15 
platelet aggregation, the margination of neutrophils on the endothelial cells, the 
formation of free radicals, intestinal necrosis, hypotension and right ventricular 
dysfunction.64 Equine platelets are very sensitive to PAF, further substantiating its 
role in equine coagulopathy. Specific PAF receptor antagonists prevent the 
hemodynamic alterations of endotoxemia,65' 66' 67 and this suggests the importance 
of PAF in the pathogenesis of endotoxemia. The adherented and activated 
neutrophils then disgorge their granules onto the endothelial cells by active 
exocytosis or after cell death, resulting in local high concentrations of elastase, 
collagenase, cathepsin G and other neutral proteases, which damage the vascular 
endothelium.68 
Activation of neutrophil membrane NADPH oxidase by cytokines leads to 
the liberation of toxic oxygen metabolites (TOMs) including hydroxyl radical and 
hypochlorous acid in a dose- and time-dependent manner.68 TOMs not only 
damage the adjacent vascular endothelial cells but also inactivate macromolecules 
involved in regulation of inflammation such as antiproteases so that the effects of 
neutral proteases are exaggerated. Damages to endothelial cells and basement 
membranes of all vascular beds by TOMs, neutral proteases, local hypoxia, and 
extravasating activated neutrophils permits leakage of plasma into the interstitial 
spaces and results in the formation of peripheral and pulmonary edema. 
Under the influences of TNF-a and IL-1, mononuclear phagocytes express 
thromboplastin-like procoagulant activity (PCA) on the surface of the cells that 
may serve as a focal point for the formation of microvascular thrombi via the 16 
extrinsic pathway of coagulation.69 The term PCA is used collectively to describe 
all clot-promoting substances synthesized by these cells and thrombomodulin is the 
highest concentration, thus the term PCA is often used synonymously with 
thromboplastin. In addition to the mononuclear phagocytes, the endothelial cells 
are also stimulated to express PCA by TNF-a and IL-1.70' n Also, TNF-a 
suppresses the protein C pathway on the endothelial cells in which the activated 
protein C in turn functions as an anticoagulant by proteolytically degrading factor 
Va and factor VIIIa. 70, 72 The exaggerated PCA by these cells results in the 
deregulation of the normal balance between coagulation and fibrinolysis and may 
be manifested clinically as thrombosis, ischemic organ failure or severe 
hemorrhage diathesis, thus will lead to disseminated intravascular coagulation 
(DIC).37 The principle sighs of DIC in horses are petechial or ecchymotic 
hemorrhages on mucous membranes and sclerae with a tendency to bleed from 
venipuncture sites.73 The result of exaggerated thrombin formation during DIC is 
widespread fibrin deposition in the microcirculation causing circulatory obstruction 
and organ hypertension that may lead to ischemic necrosis and failure. 
The consequences of vasodilation, vascular leakage and intravascular 
coagulation are systemic hypotension and inadequate tissue perfusion. The failure 
of multiple organ systems in sequence or simultaneously is a well-defined sequela 
of septic shock. The kidney, liver, lung and heart are the organs most vulnerable to 
failure. 17 
Quantitative Analysis of Endotoxin Concentration 
Various in vitro assays have been used for the detection of endotoxin to 
replace in vivo assays (the rabbit pyrogen assay and Swartzman test).74 These 
include enzyme-linked immunosorbent assays (ELISA), hemagglutination inhibition 
(HI) test, Limulus amebocyte lysate (LAL), etc. The LAL assay is preferred over 
others now, because this assay is highly sensitive, quantitative, reactive with 
biologically active component lipid A, and relatively convenient to run. 
In 1956, Bang discovered that the endotoxin of a Vibrio species from sea 
water caused fatal intravascular coagulation in the horseshoe crab (Limulus 
polyphemus) and endotoxin-induced activation of this process in vitro.75 Later, 
Levin, Bang and coworkers showed that this coagulation is the result of an 
endotoxin-induced reaction including the enzymatic conversion of a clottable 
protein derived from the circulating blood cells in this horseshoe crab called 
amebocyte.76' 77 A lysate from the amebocyte is extremely sensitive to the presence 
of endotoxin. The coagulation system of Limulus polyphemus consists of several 
enzymes which are arranged in three pathways (Fig. 3) in a fashion which 
resembles the classic, alternative, and common mammalian coagulation cascade 
pathways, the components of which activate each other in a cascade sequence. The 
coagulation system of the Japanese horseshoe crab, Tachypleus tridentatus, which 
is considered homologous to the Limulus polyphemus, has been studied 
extensively .79 18 
Endotoxin 
Factor C  Activated Factor C 
Factor B  Activated Factor B 
Proclotting enzyme  Clotting enzyme 
Fig. 3 Schematic representation of coagulation system found in 
the horseshoe crab (Limulus polyphemus) amebocyte. 
Endotoxin activates the initial enzyme (factor C) of the LAL coagulatory 
system and ultimately leads to the conversion of coagulogen, a clottable protein, 
into coagulin and peptide C.8° Coagulogen is a single basic polypeptide chain with 
a calculated molecular mass of 19.7 kDa. It contains three regions, the A chain, 
peptide C, and the B chain, of 18,28, and 129 amino acid residues, respectively. 
On gelation, peptide C is released by the amidase activity of the clotting enzyme 
and the two chains of the chain A and B form the gel by two disulfide bridges (Fig. 
4). 19 
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Fig. 4 Peptide linkages of coagulogen (A chain, Peptide C, and B chain) 
and the sites cleaved by LAL clotting enzyme. 
In the original version of the LAL assay called the gel clot LAL assay, the 
endotoxin-activated clotting enzyme cleaves the coagulogen to form a clot and, 
after an appropriate incubation time, if a firm gel clot is formed, the test is scored 
positive. This assay is simple to perform but lacks an objective end point because 
the method relied upon visual judgement of the gel formation and is not strictly 
quantitative, but rather qualitative assay. To overcome this limitation, various 
methods to quantify the progress of the reaction leading to coagulogen conversion 
have been employed. For example, through monitoring the increase in turbidity,81' 
82  the loss of coagulogen as the clot forms,83' 84  the increase in precipitated 
protein,85. 86 or the appearance of a peptide cleavage fragment of coagulogen.8° 
They were quantitative, objective and more sensitive. 
Later, a new assay method which utilizes synthetic chromogenic substrate 
has been developed called chromogenic LAL assay.87 In this assay, the coagulogen 20 
is completely or partially removed to be replaced by a chromogenic substrate,88 
which is a small synthetic peptide linked to a chromophore (para-nitroaniline, or 
pNA) containing an amino acid sequence similar to that present at the site where 
the amino acid residues are X-Y-Gly-Arg-pNA in the clotting protein cleaved by 
the clotting enzyme (Fig. 4, 5). 
Chromogenic substrate  Clotting enzyme 
Boc-Val- Leu-Gly-Arg-CONH, -NO2 + H2O i 
Boc-Val-Leu-Gly-Arg-OH + H2N-C-NO 
pNA 
Fig. 5 A typical chromogenic substrate for LAL clotting enzyme. 
pNA is read spectrophotometrically at 405 nm. 
The chromogenic LAL assay usually has two stages: a LAL activation stage 
and followed by the addition of the chromogenic substrate to the reaction mixture, 
a chromophore release stage. Release of the chromophore imparts a yellow color to 
the solution, and the strength of this color as measured by optical density at 405nm 
in a spectrophotometer is a function of the amount of active clotting enzyme, thus 
indirectly to the amount of endotoxin in the solution. The greater the endotoxin 
concentration in the specimen, the faster pNA will be released. The chromogenic 
reaction is time- and temperature-dependent, but within these limitations the 
sensitivity is as low as 1 pg/m1.89 21 
The LAL test was originally considered to be specific for endotoxin until 
Kaminuma, et al found that carboxymethylated (1 -3)-P-D-glucan also contributes 
to the LAL coagulation enzymes (Fig. 6),90 however, the concentration required 
for P-D-glucan to initiate the LAL coagulating system was 1,000 to 100,000 times 
higher than that of endotoxin. 
(1-3)-P-D-glucan
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Fig. 6 A (1-3)-P-D-glucan mediated pathway linked with the 
activation of proclotting enzyme. 
Although the LAL assay has been used to monitor endotoxin contaminations 
of pharmaceuticals and medical devices, there are potential problems associated 
with measurement of endotoxin in blood, owing to the presence of endotoxin 
inhibitors in plasma such as a-plasmin inhibitor and antithrombin III belonging to 
plasma proteinase inhibitors.90' 91 They strongly inhibit the amidase activity of the 
clotting enzyme and can give rise to a false-negative result. Also, because the 
proclotting enzyme of the LAL shares several properties with mammalian 
coagulation factors such as factor Xa, factor XII, and a-thrombin, in that both of 
them require calcium and are inhibited by diisopropyl fluorophosphate, and the 22 
presence of gamma-carboxy-glutamic acid, and they also function as serine 
proteases, therefore there is a theoretical possibility of activation of LAL by the 
plasma coagulation factors, which might lead to a false-positive result.28 
Therefore the quantitation of the endotoxin in circulating blood or plasma 
cannot be directly applicable for the LAL assay. Some pretreatment on the blood 
plasma samples should be required for the LAL assay, and dilution followed by 
heating has become the method of choice for the pretreatment of the plasma sample 
because of its simplicity and superior efficacy.92 A typical set of inactivation 
condition is a dilution with pyrogen-free water (1:10) and heating at greater than 
70C for 10 minutes.28 Piotrowicz, et al reported that the temperature of 100C 
appeared to be clearly superior to the temperature of 75C.92 
By means of Chromogenic LAL assay, the normal endotoxin level in 
plasma of healthy animals was below 1 pg/ml in pig, horse, cow and chicken 
93 
below 6.25 pg/ml in rabbit,94 below 9 pg/ml in dog and below 12 pg/ml in rat,95 
and 31.9 to 65.3 pg/ml in rainbow trout.95 In contrast, the endotoxin levels in 
plasma collected from diseased animals were much higher than the normal status. 
For example, in cows infected with Escherichia Coli, the endotoxin level was 124 
± 47.3 pg/ml. In cows affected with gangrenous mastitis with gram negative 
bacteria, the endotoxin level was 72.5 ± 8.7 pg/ml, whereas in horses with colic 
followed by poor prognosis, the endotoxin level was 10 pg/m1.97 23 
Liver Function Tests in Equine Colic and Endotoxemia 
Some colic patients referred to Oregon State University veterinary teaching 
hospital exhibited the coincidental increased serum bile acids and y-GT, which 
suggests hepatobiliary dysfunction or hepatic damage (data not shown). Tennant 
reported that approximately 15% of horses with colic showed the clinical sign of 
icterus and the degree of icterus was only moderate, and the sclera was never as 
deep yellow in color as that seen in hepatic insufficiency.98 
It has been recognized that an elevated concentration of serum bile acids is a 
highly specific indicator of the hepatobiliary dysfunction.99' 1°°' " Bile acids are 
produced only in the liver from cholesterol and all contain a 3-hydroxy group in 
the a position.99 Bile acids are excreted to the intestine with amino acid 
conjugation, especially glycine and taurine. The types of amino acid conjugation 
differ between species and in horses, 86% of bile acids are conjugated with taurine. 
Amino acid conjugation enhances bile acids to form micelles for fat absorption.lin 
The amount of bile acids secreted to intestine usually depends upon the time of 
feeding.' However, because horses do not possess a gall bladder, and have a 
very weak sphincter of the common bile pancreatic duct, the bile acids are 
continuously secreted into the lumen of the intestine.103 Compared with other 
animals with a gall bladder, horses may not be affected by the time of sampling to 
assay the level of serum bile acids. 
The daily synthesis of total bile acids in horses is much less than in other 
species, while the secretion rate of bile acids to intestine is similar. Therefore the 24 
rate of bile acids for the enterohepatic cycling is higher in horses than in other 
species. It has been estimated that in ponies the bile acids are circulating about 38 
times per day. 
120  Bile acids are normally restricted (over 90%) to the enterohepatic 
circulation.") Therefore serum bile acids concentrations are normally low (less 
than 18 irmol/L). In hepatobiliary diseases, the liver fails in its ability to extract the 
serum bile acids and excrete them into hepatic bile.121 Subsequently, the serum bile 
acids concentration is increased. Besides the failure of liver function, if there is 
extra- or intra-hepatoboliary blockage of bile flow or portal vein, causing leakage 
of bile acids to the systemic circulation. 
The serum y -GT (gamma glutamyl-transpeptidase) is produced from the 
biliary epithelium and has its most dramatic elevations in the serum of most 
species, including horses, with biliary disease and obstruction.'°3 The normal 
range is between 8 to 30 IU/ml. The function of this enzyme is to catalyze the 
transferring of gamma glutamyl groups from glutamyl peptides to an acceptor 
peptide or L-amino acids."9 The highest concentrations of y-GT are found in the 
kidney, pancreas and liver. However, the elevation of serum y -GT is generally 
considered to be hepatic origin in horses, because pancreatic disease is very rare in 
horses, and renal disease results in y -GT release into the urine and not in the 
103 serum. 
In equine colic, the presence of endotoxin and the extra-hepatobiliary 
obstruction may result in increased serum bile acids and y -GT concentrations. 
Nitsche et al. reported that there was a correlation between endotoxin and the liver 25 
function in human septic patients.106 Endotoxin is considered to mediate the 
production of cytokines from mononucleated cells including macrophages and 
monocytes.61 Previous study showed that TNF-a has been implicated in the 
pathogenesis of the endotoxin mediated-hepatotoxicity (liver injury) caused by 
promoting the accumulation of neutrophils in the liver.107 Extra-hepatobiliary 
obstruction was reported by Divers, et al. in which two colic cases with large 
colon displacement obstructed the biliary system.'°3 26 
Chapter 2. 
Chromogenic Limulus Amebocyte Lysate Assay for Equine Plasma : 
Evaluation of Control Endotoxin Standards 27 
Summary 
To determine endotoxin in equine plasma, a chromogenic Limulus 
amebocyte lysate (LAL) assay was applied, and its sensitivity and reproducibility 
were evaluated. A linear relationship with correlation coefficient of greater than 
0.90 was observed in the both pyrogen-free water and absorbed equine plasma 
endotoxin standards between LPS concentrations in logo and OD405 read between 
40 and 45 minutes of incubation time. The recovery rates of LPS in equine plasma 
were from 84.146 % to 136.395 % with overall 107.786 + 24.340 % based on the 
OD values of the LPS amounts in pyrogen-free water as 100 %. Despite the efforts 
to reduce interfering factors in plasma by the dilution-heating treatment, some 
nonspecific reaction(s) were observed with plasma. The precision of endotoxin 
standards (CV) between pyrogen-free water and absorbed equine plasma were 
between 19.427 % and 34.007 % at various LPS concentrations. 
The CV for intra-assay precisions among four different plasmas were 
between 4.225 % and 10.436 %, and the recovery rates were constant with overall 
100.196 ± 8.916 % based on the OD values of the LPS amounts in an arbitrary 
selected plasma as 100 %. Also, the CV for inter-assay precision for repeatedly 
measured at six different plates on different days was 15.056 %. The limit of 
sensitivity in plasma was 6.25 pg/ml. 
It was found that it was unreliable when the pyrogen-free water was used to 
make endotoxin standard solutions. It was an essential to use the absorbed equine 28 
plasma to make endotoxin standard solutions that have been treated by the same 
pretreatment procedure as for the samples. 
Introduction 
Endotoxin or lipopolysaccharide (LPS) is a component of the outer cell 
membrane of gram-negative bacteria, and is responsible for many pathophysiological 
reactions in vivo and in vitro.' These biological reactions are mediated by lipid A, a 
hydrophobic portion of LPS. Because of biological significance, the detection of 
endotoxin in various media is important in biomedical fields. Procedures such as 
passive hemagglutination test, enzyme-linked immunosorbent assay (ELISA), rabbit 
pyrogen assay have been used in the past for the detection of endotoxin. In 1956, 
Bang observed intravascular coagulation of horseshoe crabs when they were infected 
with Vibrio bacteria.' Based on the observation, a highly sensitive detection method 
was developed by the use of amebocyte of the horseshoe crab.'' 
Limulus amebocyte lysate (LAL) test has been used extensively for detecting 
endotoxin in various materials including blood.' A variation of the test, 
chromogenic LAL test, was developed in 1978 and used in clinical fields for its 
sensitivity and ease in quantitation. 87 In determining endotoxin in equine blood, 
Henry and Moore reported that sensitivity of the chromogenic LAL test to detect 
LPS was 2 pg/ml in equine plasma and that 9 out of 30 colic horses had endotoxin in 
plasma with the mean concentration of 20 pg/m1.97 The authors, however, failed to 
mention detailed procedures for the determination including positive and negative 29 
controls. Fess ler, et al. found that the sensitivity of the chromogenic LAL test was 
validated for 10 pg/ml, and the recovery rates, inter-assay precision, and intra-assay 
precision were 90 to 106, 11, and 5.5 %, respectively, using standard LPS 
reconstituted in equine plasma.'" 
The present investigation was initiated to quantitate endotoxin in plasma of 
colic horses. During the course of the study, it was found that selection of proper 
LPS standards was essential to obtain meaningful results. 
Materials and Methods 
Glasswares  All glasswares and metal caps were soaked in 1% solution of 
detergent (E-Toxa-Clean; Sigma Chemical Co., St. Louis, Mo) dissolved in double 
distilled water for at least 12 hours and they were rinsed well with double distilled 
water and pyrogen-free water (Bio*Whittaker, Walkersville, MD). Glass test tubes 
(13 x 100 mm) were covered by metal caps, autoclaved at 121C for 1 hour, and 
baked at 230C for at least 5 hours. 
Standard Endotoxin  Phenol-extracted LPS derived from Eschelihia coli, 
strain 055:B5 (Difco Laboratory, Detroit, MI) was used as a standard. The LPS 
was reconstituted with pyrogen-free water to make 1,000 pg/ml solution and 
dispensed into pyrogen-free plastic tubes and kept at -70C. 30 
Plasma  Plasmas were obtained from four different clinically healthy 
horses. The area around either side of the jugular veins was clipped and scrubbed 
with 5% iodine and 70% alcohol. Twenty milliliter of whole blood was taken 
directly into a syringe containing 200 units of sterile sodium heparin. The blood 
was immediately transferred to the pyrogen-free glassware placed on ice and later 
centrifuged at 1,000 x g for 10 minutes at 4C. Plasma was separated and stored at 
70C. 
Endotoxin Absorption  Ten milliliter of each plasma was added into the 
endotoxin removal affinity resin (END-X B52; Associates of Cape Cod, Inc., 
Woodshole, MA) and mixed with a rotator for 8 hour at 4C. The mixture was 
centrifuged at 1,000 x g for 3 minutes at 4C, and the supernatant was transferred 
into a pyrogen-free tube supplied with the resin and kept at -70C (absorbed equine 
plasma). 
Endotoxin Standard  The stock LPS (1,000 pg/ml) was added to 
pyrogen-free water and absorbed equine plasmas to make endotoxin standard 
solutions; the final endotoxin concentrations were between 0.625 and 10 pg/ml in 
pyrogen-free water and between 6.25 and 100 pg/ml in absorbed equine plasma. 
Inactivation of Plasma  To reduce inhibiting and enhancing factors in 
the plasma constituent, 100 Al of each plasma sample containing LPS was diluted 31 
with 900 pl of pyrogen-free water in a tube and heated for 10 minutes in boiling 
water bath. 
Chromogenic Limulus Amebocyte Lysate (LAL) Assay  Fifty 
microliters of each standard sample from pyrogen-free water and plasmas were 
distributed into wells of the microtiter plate (Microwell; Nunc, Roskilde, 
Denmark) in triplicates. Subsequently 50 µl of the mixture of Limulus amebocyte 
lysate and chromogenic substrate (Pyrochrome; Associates Cape Cod, Inc., 
Woodshole, MA) was added. The plate was mixed gently and incubated at 37C. 
The optical density at 405 nm was read with an automatic ELISA reader (Multiskan 
MK II; Flow Laboratories, McLean, VA) with 5 minute intervals. The results were 
plotted with the 0. D. value (0D405) on the Y axis and the LPS concentrations in 
common log (logio pg/ml) on the X axis by the use of a computer program 
(SigmaPlot; Jandel Scientific Software, San Rafael, CA). In an experiment, eight 
plates were prepared for the statistical analysis, in which a plate was used for the 
comparison between pyrogen-free water and plasma standards, another plate was 
used for the comparison among the four different plasmas. The other plates were 
used to evaluate the plate-to-plate variation in which these six plates were assayed 
for plasmas of 5.0 pg/ml of LPS concentration for six different days. 
Statistics  Sensitivity was evaluated for absorbed equine plasma by 
determining the lowest detectable LPS concentration that was significantly 32 
(P < 0.05) different from 0 pg/ml (without adding any LPS to the absorbed equine 
plasma) using a Student-t test. 
Every OD values were required to be subtracted from the control OD value, 
which was 0 pg/ml of LPS concentration, followed by the calculating for the 
coefficient of variation (CV) and recovery rates. The precision of endotoxin 
standards (CV) between pyrogen-free water and absorbed equine plasma at every 
LPS concentration was determined by a triplicated manner within an assay. The 
recovery rates for the OD values of every LPS concentration in plasma were 
calculated with OD values of the LPS amounts in pyrogen-free water as 100 %. 
The coefficient of variation for intra-assay precision was determined at each 
LPS concentration by a triplicated manner of four different plasma samples within 
one assay. The CV for inter-assay precision was also determined for 5.0 pg/ml of 
LPS concentration by six repeated measurements on aliquots of the same sample on 
different days. Also, the recovery rates for every LPS concentration were 
calculated with the OD values of the LPS amounts in an arbitrary selected plasma 
as 100 %. 
Results 
The rate of chromophore release (OD increase) was proportional to the LPS 
concentrations in both pyrogen-free water and plasma (Fig. 7, 8). As shown in Fig. 
7, the pyrogen-free water control (0 pg/ml) containing the lysate and chromogenic 
substrate mixture resulted in a nonspecific manner of the releasing chromophore 33 
dye in delayed and slower fashion. To make sure that this is not due to a minute 
amount of LPS in the solution, the pyrogen-free water was treated with the 
endotoxin absorbance resin to remove any LPS in the water. This attempts, 
however failed to show any notable change in the chromophore release compared 
with the non-treated pyrogen-free water (data not shown). 
When the LPS standards in absorbed plasma were tested in the assay, 
substantially higher O.D. values were observed in the plasma than in pyrogen-free 
water at every LPS concentration. Furthermore, nonspecific reaction (0 pg/ml 
controls) were also greater in the absorbed plasma than pyrogen-free water 
endotoxin standard. Compared with the pyrogen-free water control, standards and 
control (0 pg/ml) in plasma formed some precipitations, making hazy appearance. 
With the range of LPS concentrations (0.625-10.0 pg/ml), a linear 
relationship with correlation coefficient greater than 0.90 was observed in both 
endotoxin standards between the LPS concentration in logio and OD values 
readings obtained at 40 and 45 minutes of incubation (Fig. 9, 10). Because of the 
different degrees of the nonspecific reaction, the standard curves of the 
chromogenic LAL assay resulted in different slopes between the pyrogen-free 
water and absorbed plasma endotoxin standard (Fig. 11). 34 
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Fig. 8 Chromogenic LAL assay reaction curve with E.Coli 055:B5 
LPS added to absorbed equine plasma. 
Vertical axis values represent mean, n=3. 36 
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Fig. 11 Comparison of the standard curves of chromogenic LAL assay 
in pyrogen-free water and absorbed equine plasma. 39 
The precisions of endotoxin standards (CV) between the pyrogen-free water 
and absorbed equine plasma at 0.625, 1.25, 2.5, 5.0 and 10.0 pg/ml of LPS 
concentration were 33.254, 34.007, 20.540, 19.427, and 20.014 %, respectively 
(Table 3). The mean recovery rates at each LPS concentration were gradually 
increased from 84.146 % at 0.625 pg/ml to 136.395 % at 10.0 pg/ml with overall 
107.686 ± 24.340 % (mean ± s.d.). 
Table 3 Precisions of endotoxin standards (CV) and recovery rates of 
the standard from absorbed equine plasma compared to that of 
pyrogen-free water 
LPS concentration (pg/ml)  CV (%)  Recovery rates (%) 
0.625  33.254  84.146 
1.25  34.007  92.835 
2.5  20.540  93.500 
5.0  19.427  131.552 
10.0  20.014  136.395 
An arbitrary plasma out of four plasma was chosen as a standard (control) 
to determine the CV and recovery rates. Became of the limitation of the number of 
the wells and the triplicate procedures of each sample, 10 pg/ml of LPS 
concentration was unable to examine. The CV for the intra-assay precision for at 
0.625 pg/ml, 1.25 pg/ml, 2.5 pg/ml, and 5.0 pg/ml of each LPS concentration 
were 8.646 %, 10.346 %, 10.436 %, and 4.225 %, respectively (Table 4). 40 
Table 4 CV for the intra-assay precision and recovery rates among 
plasmas with an arbitrary selected plasma LPS standard as 100 °A 
LPS concentration (pg/ml)  CV (%)  Recovery rates (%) 
0.625  8.646  113.342 
1.25  10.346  96.615 
2.5  10.436  93.519 
5.0  4.225  97.318 
The CV for the inter-assay precision at 5.0 pg/ml of LPS concentration for 
repeatedly measured different six plates at different days was 15.086 %. The 
recovery rates were between 93.318 % and 113.342 % with overall 100.196 ± 
8.916 % (mean ±s.d.). 
With the pyrogen-free water, a linear correlation between LPS 
concentrations in log,, and the OD values was demonstrated down to 0.1 pg/ml 
level (data not shown). However, with equine plasma, which had been pre-
absorbed for LPS and subsequently reconstituted with various amounts of LPS was 
used, the limit of sensitivity, the smallest amount of LPS in equine plasma 
measured reliably, was 0.625 pg/ml in diluted solution (1:10) or 6.25 pg/ml in 
equine plasma (Table 5). 41 
Table 5 Limit of sensitivity in detection of LPS in absorbed equine plasma 
0D405 at each LPS concentration  P-value 
0 pg/ml  vs  0.625 pg/ml  0.0462 
(0.2070 ± 0.0280)  (0.3340 + 0.0716) 
0 pg/ml  vs  1.25 pg/ml  0.00125 
(0.3733 ± 0.0210) 
0 pg/ml  vs  2.5 pg/ml  0.00414 
(0.5443 ± 0.0458) 
0 pg/ml  vs  5.0 pg/ml  0.00008 
(0.6520 + 0.0367) 
0 pg/ml  vs  10.0 pg/ml  0.000017 
(0.6857 ± 0.0189) 
Number in parenthesis indicates mean ± s.d. of O.D. values at 405 nm. 
Discussion 
The chromogenic LAL assay is superior to other forms of LAL assay in 
terms of its high sensitivity (as low as 1 pg/ml) and ease in quantitative 
measurement.' The rate of chromophore release (increase in the 0. D. value ) was 
proportional to LPS concentrations in the present form of chromogenic LAL test . 
By the use of endpoint method, 0. D. readings at 40 to 45 minutes of incubation 
consistently showed a linear relationship with LPS concentrations in a log scale 
within the range of LPS concentrations tested. However, the results of the present 
study indicate that the LPS in plasma cannot be assessed accurately when LPS 
standards in pyrogen-free water is used as recommended in some commercial test 
kits. 42 
There was apparent difference in the rate of chromophore release between 0 
pg/ml control standards of pyrogen-free water and that in the absorbed equine 
plasma (Fig. 7, 8). At 40 minutes of the incubation, for example, 0 pg/ml control 
in pyrogen-free water showed O.D. value of 0.10 while that in the plasma was 
0.18; at 60 minutes, it was 0.21 in pyrogen-free water and 0.32 in the plasma. 
Compared with pyrogen-free water, absorbed equine plasma endotoxin standard 
showed hazy appearance which seems to have increased O.D. value. This appears 
due to the formation of fine precipitate. Previous study showed that a component of 
plasma, probably degraded fibrinogen by the heat treatment reacted with LAL 
coagulogen, and enhanced the development of turbidity in the LAL reaction.108 
Fibrinogen concentration of 250 mg /dl in heated plasma could mimic an apparent 
concentration of endotoxin of 0.1 endotoxin unit/nil in chromogenic LAL assay. In 
horses, normal range of plasma fibrinogen concentration is between 100 and 400 
mg/d1.115 Another possibility is the coagulin formation converted from the residual 
coagulogen by the clotting enzyme,
79  even the coagulogen is supposed to be 
blocked for the use in the chromogenic LAL test.'°9 However, no investigation 
was done in the present study to elucidate the mechanism of this interference. In 
chicken plasma, granular precipitate formation was reported by the addition of 
Limulus lysate.116 
Besides the nonspecific reactions mentioned above, as shown in Fig. 11, the 
LPS standard in plasma had a steeper slope than corresponding standard in 
pyrogen-free water after the subtraction of 0 pg/ml controls, indicating different 43 
rates of enzymatic reactions. The Limulus lysate contains multiple enzymes that 
participate in the cascade reactions when exposed to LPS. Without analyzing each 
enzymatic reaction with a purified enzyme, the exact mechanism was not be 
elucidated to explain this phenomenon. The heating procedure may contribute to 
enhance the interaction between the clotting enzyme systems and lipid A, causing 
apparent increase in yield in comparison to that in pyrogen-free water."° 
The precisions of endotoxin standards (CV) between the pyrogen-free water 
and absorbed equine plasma at each LPS concentration was  19.427 to 34.254 %, 
indicating substantial difference in O.D. values. Instead of pyrogen-free water, 
plasmas treated by the dilution and heating procedure were compared for the CV 
for intra-assay precisions and recovery rates. The CV for intra-assay precision was 
approximately 10 % at each LPS level, and the recovery rates were constant, 
providing approximately 100 % in the LPS concentrations of 0.625 pg/ml up to 5.0 
pg/ml. In terms of the limit of sensitivity in the chromogenic LAL assay, the 
smallest amount of LPS in equine plasma measured reliably, was 0.625 pg/ml in 
diluted (1:10) or 6.25 pg/ml in equine plasma. 
To avoid any false result, it was essential to use a plasma for positive 
endotoxin standards that have been treated by the same pretreatment procedure as 
for the samples. Fess ler et al. reported that the chromogenic LAL assay was 
validated for sensitivity (10 pg/ml), recovery rates  (90 to 106 %), intra-assay 
precision  (CV=5.5 %), and inter-assay precision (CV=11 %) on the basis of 
control standard using equine plasma."" They, however did not absorb residual 44 
endotoxin. Considering the above findings, data obtained in other studies in which 
proper endotoxin standards were not prepared in plasma may be unreliable. 45 
Chapter 3. 
Measurements of LPS Concentrations and Liver Function Tests 
in Equine Colic 46 
Summary 
Thirty-two horses with colic were assayed for plasma LPS concentration, 
the level of serum bile acids, and serum y-glutamyl-transpeptidase (y-GT) activity. 
The results were analyzed in their relationship, and evaluated their predictable 
values to the prognosis of colic cases. 
All measurements were made at the time of admission when horses were 
referred to the OSU veterinary teaching hospital with symptoms of colic. The 
horses were categorized into two groups based on the prognosis; survival or 
nonsurvival (death or euthanasia) group. Another two groups were categorized 
based on the plasma LPS concentrations in which horses with greater than the limit 
of sensitivity in the chromogenic LAL assay (6.25 pg/ml of LPS in plasma) was 
allocated to the LPS-positive and those with less than that to the LPS-negative 
group. 
Level of plasma LPS concentration failed to predict the prognosis of equine 
colic in the present study. Of 32 cases, LPS was detected in the plasma of only 6 
horses; 4 in the survival (n=15) and 2 in the nonsurvival (n=17) group. Nine 
horses had ischemic intestine, however only one had LPS detected in the plasma 
(7.635 pg/ml). 
There were no significant differences in serum bile acids and y-GT 
concentrations between LPS-positive and LPS-negative group (P=0.281, and 
0.377, respectively), nor were there any differences in serum bile acids and y-GT 47 
concentrations between survival and nonsurvival group (P=0.137, and 0.244, 
respectively). 
Introduction 
Colic is a collective term for clinical signs of acute, chronic, or recurrent 
symptoms of abdominal pain resulting from potentially life-threatening diseases of 
the gastrointestinal tract of horses.' If the blood supply to the intestines or even the 
mucosa itself is diminished because of the severe impaction, inflammation, 
strangulation, volvulus, torsion, or thromboembolism, the barrier function of the 
mucosa may be lost.37 Consequently, as the gastrointestinal tract normally has 
large amounts of endotoxin, especially in the large colon,30 endotoxin traverses the 
intestinal wall through the destroyed mucosal barrier and enters the systemic 
circulation via the mesenteric venous system, the lymphatics, or the peritoneal 
cavity, resulting in endotoxemia.34' 42 Endotoxemia is a leading cause of death in 
horses.31 
The objective of this study is to evaluate the sensitivity of prognostic value 
of plasma LPS in equine colic. Henry and Moore reported that endotoxin was not 
detected in plasma from clinically normal horses, and that endotoxin was most 
commonly detected in plasma of colic horses with ischemic intestine requiring 
resection.`)' The authors also reported that all colic horses with plasma LPS 
concentrations greater than 10.0 pg/ml did not survive, however, they failed to 
mention detailed procedures for preparing positive and negative controls. 48 
Another objective of this research is to evaluate the correlation between 
level of plasma LPS in equine colic and liver function tests, and that between 
prognosis of colic and liver function tests. Since it is easier to run tests and earlier 
to get results in liver function tests
117, 118, 119  than in the detection of LPS in the 
plasma,87  it will be presented in this section about the possiblility of liver function 
tests to evaluate an endotoxemic status in equine colic, rather than the chromogenic 
LAL assay. In colic, hepatic failure may be induced accompanying with increased 
serum bile acids and/or y-GT concentrations, caused by the obstruction of biliary 
system with displaced large colon,m or endotoxin-mediated liver injuries.107 
Serum bile acids and y-GT concentrations are currently used as liver function tests 
because they are highly specific to liver function in horses.103 
Material and methods 
Horses 32 horses with colic admitted to the Veterinary Teaching 
Hospital, Oregon State University from August, 1996 to November, 1996. 
Categorizations of Colic Horses  For the categorization of the plasma 
LPS concentration data, each horse with colic was placed into one of five broad 
diagnosis groups on the basis of observations made during initial physical 
examination, surgery, or necropsy findings; impaction, peritonitis, large colon 
displacement, ischemic intestine, and inflamed intestine group. The impaction 
group included horses with a large- or small-colon impaction with ingesta, gas, or 49 
enterolith. Horses with peritonitis had increased peritoneal fluid white blood cell 
count greater than 50,000 cells/Al regardless the presence of bacteria in peritoneal 
fluid. The large colon displacement group contained horses without requiring 
resection such as large colon displacement or some large colon torsion and 
volvulus confirmed by rectal palpation, surgery, or necropsy. Horses in the 
ischemic intestine group had either ischemic small- or large- intestine requiring 
resection including small intestine strangulation, large colon torsion, volvulus, or 
thromboembolism. Horses with inflamed intestine included those with proximal 
enteritis, colitis or toxins. 
Each horse within the group was also assigned to one of two outcome 
categories, survival or nonsurvival group. Nonsurvival groups included horses that 
died or were euthanized because of a grave prognosis. 
Horses with plasma LPS concentration greater than limit of the sensitivity 
in the chromogenic LAL assay (6.25 pg/ml in plasma) were categorized in LPS-
positive group and those with less than that were in LPS-negative group. 
Sample Collection Blood samples were aseptically collected from the 
jugular vein at the time of admission, i.e., prior to the establishment of a definitive 
diagnosis. The collection, handling, and laboratory protocol for the plasma samples 
from the horses with colic were identical to that described for the experimental 
study in Chapter 2. The serum was a so obtained for liver function tests and kept at 
-70C untill the tests could be performed. 50 
Bacterial Cultures The aliquots of plasma (0.1 ml) collected from horses 
with colic were used for the bacterial cultures plated onto a 5% blood agar plate 
and Mackonkey agar plate. The plates were incubated at 37C and checked every 24 
hours for 72 hours of incubation. 
LPS determination  Same method described previous chapter was 
executed in which the dilution and heating procedure (dilution and heating) was 
taken for both endotoxin control standards and samples. The O.D. value was read 
after 40 minutes of incubation. In the chromogenic LAL assay for equine plasma as 
described in the previous chapter, the limit of sensitivity was 0.625 pg/m1 in 
diluted (1:10) or 6.25 pg/ml in plasma. 
Serum bile acids measurement  Serum bile acids concentration was 
assayed enzymatically and colormetrically by use of 3a-hydroxysteroid 
dehydrogenase (3a- HSD). "7 3a-HSD oxidizes 3-a-hydroxy bile acids to the 
corresponding 3-oxo bile acids with a simultaneous stoichiometric generation of 
NADH from NAD. This NADH was then reduced by the enzyme Diaphorase to 
NAD and at the same time Diaphorase oxidizes Nitro Blue Tetrazolium (NBT) to 
form the tetrazolium salt with subsequent formation of Formazan. Formazan was 
the end product and had a blue color which was read at O.D. value at 540 nm by 
use of an automated spectrophotometer (550 Express; Ciba Corning, Oberlin, OH). 51 
3-a-hydroxy bile acids + NAD  > 3-oxo bile acids + NADH 
3a-HSD 
NADH + NBT  > NAD + Formazan 
Diaphorase 
Serum y-GT concentration  Serum y-GT was assayed by the rate of 5­
amino-2-nitrobenzoate formation in which y-GT catalyzed the transfer of the y­
glutamyl group from L-y-glutamy1-3-carboxy-p-nitroanilide to glycylglycine.118,119 
The O.D. value was read at 405 nm by use of an automated spectrophotometer 
(550 Express; Ciba Corning). 
L- y- glutamyl -3- carboxy -p- nitroanilide + glycylglycine 
> 5-amino-2-nitrobenzoate + L-y-glutamylglycylglycine 
y-GT 
Statistical analysis  Serum bile acids and y-GT concentrations between 
survival and nonsurvival group were statistically analyzed by Student-t test. Also, 
serum bile acids and y-GT concentrations between LPS-positivet and LPS-negative 
group were statistically analyzed by Student-t test. The level of significance was set 
at P<0.05. 52 
Results 
No bacteria was detected in the plasma of 32 horses with colic even though 
several horses had severely necrotic intestine revealed at surgery or necropsy (data 
not shown). 
Of the 32 horses with colic, 26 horses were LPS-negative and 6 were LPS-
positive (mean; 14.93 pg/ml; range, 7.0 to 42.18 pg/m1 ; Table 6, 7). 
Table 6 Diagnosis, plasma LPS, serum bile acids, serum y-GT 
concentrations and the outcome of the horses with colic 
No.  Diagnosis  plasma LPS  SBA  y-GT  Outcome 
(pg/ml)  (Knol/L)  (IU/ml) 
1  Peritonitis  42.18  12  21  L 
2  SI strangulation  <6.25  1  16  E* 
3  Tansy poisoning  <6.25  152  145  E 
4  SI strangulation  <6.25  21  19  E* 
5  Gas colic  <6.25  11  20  L 
6  LC displacement  <6.25  50  66  E 
7  LC torsion  <6.25  56  31  E 
8  SI strangulation  <6.25  20  22  E 
9  SI strangulation  <6.25  7  17  E* 
10  SC volvulus  <6.25  13  12  E* 
11  SI strangulation  <6.25  31  108  E* 
12  SI adhesion  7.518  2  27  E* 
13  Gas colic  <6.25  8  11  L 
14  LC impaction  <6.25  8  13  L 
15  Granulomatous enteritis  7.748  8  8  L 
16  LC displacement  <6.25  6  7  D* 
17  LC torsion  <6.25  5  19  L* 
18  LC displacement  <6.25  8  11  E 
19  LC displacement  17.49  10  8  E 
20  LC displacement  7.0  7  15  L* 
21  LC torsion  <6.25  18  19  L* 
22  Peritonitis  <6.25  16  23  E 
23  Gas colic  <6.25  9  55  L 
24  Enterolith  <6.25  8  14  L* 53 
Table 6 (continued) 
No.  Diagnosis  plasma LPS  SBA  y-GT  Outcome 
(pg/ml)  (psnol/L)  (IU/m1) 
25  Peritonitis  <6.25  4  53  E 
26  LC impaction  <6.25  20  16  L 
27  LC displacement  <6.25  15  26  E 
28  SI strangulation  7.635  5  41  L* 
29  SI strangulation  <6.25  5  30  E 
30  Peritonitis  <6.25  9  25  L 
31  Enterolith / LC volvulus <6.25  14  42  L* 
32  Thromboembolism  <6.25  28  12  E 
SBA : serum bile acids 
SI : small intestine  LC : large colon  SC : small colon 
L : lived  D  : dead  E  : euthanasia  *  : surgery was done. 
Of these 6 LPS-positive horses, only 3 horses were applicable for surgical 
intervention. Of 32 colic horses, 15 horses survived and 17 horses dies or 
euthanized. Four of 6 LPS-positive horses were belonging to survival group, and 2 
of them were to nonsurvival group. Impaction group (n=7) had a excellent 
prognosis and no horse in this group could detect LPS in plasma. The prognosis of 
peritonitis group (n=4) was dependent on each case, 2 survived and 2 euthanized. 
A horse in this group (No. 1) had very high plasma LPS concentration (42.18 
pg/ml), however this horse survived. In the large colon displacement group 
(n=9), 2 horses had LPS detected in plasma. One of them (No. 20) had surgery 
and survived. Another case (No. 19) did not go for the surgery and euthanized. 
This horse had higher plasma LPS concentration, even though the necropsy finding 54 
showed that the mucosal layer of the large colon was not severely damaged. Only 1 
horse (No. 28) in the ischemic intestine group (n=9) had LPS detected in plasma, 
however this horse survived. Two colic cases (No. 12, 15) in the inflamed intestine 
group (n=3) had LPS detected in plasma. Therefore, LPS was not commonly 
detected in plasma of horses with ischemic intestine requiring resection, but was 
detected in various groups including 1 peritonitis, 2 inflamed intestine, 2 large 
colon displacement, and 1 ischemic intestine group (Table 7). 
Table 7 Summary of categorization of colic, plasma LPS concentration, 
and prognosis of the horses 
LPS 
concentration 
Prognosis 
Diagnosis  (pg/ml of plasma)  Survival  Nonsurvival 
Impaction  7  0 
Peritonitis  42.18  2(1)  2 
LC displacement  17.490, 7.0*  4(1)  5(1) 
Ischemic intestine  7.635*  1(1)  8 
Inflamed intestine  7.748, 7.518*  1(1)  2(1) 
Number in parenthesis indicates the number of horses in that group that had 
detected LPS in plasma.  *  : surgery was done. 
The mortality rate was 33.33 % in LPS-positive and 65.38 % in LPS-
negative (Table 8). The mean serum bile acids and y-GT concentration for LPS-
positive group were 7.33 ± 3.56 ,umol/L and 20.00 ± 12.68 IU/ml, respectively 
(mean ± s.d.). Those for LPS-negative group were 20.88 ± 29.83 ,umol/L and 
32.00 ± 12.68 IU/ml, respectively (mean ± s.d.). There was no significant 55 
difference in serum bile acids concentration between LPS-positive and LPS-
negative group (P=0.281). There was no significant difference in serum y-GT 
concentration between LPS-positive and LPS-negative group (P=0.377). 
Table 8 Mortality and liver function tests * in colic horses in LPS-positive 
and LPS-negative group 
LPS-positive (n=6)  LPS-negative (n=26) 
Mortality (%)  33.33 (n=2)  61.53 (n=16) 
serum bile acids (Amon)  7.333 + 3.56  20.884 ± 29.83 
serum y-GT (IU/ml)  20.00 ± 12.68  32.00 ± 12.68 
* Data are expressing as mean ± s.d. 
The mean serum bile acids and y-GT concentrations for survival group were 
10.143 ± 4.487 Amon and 22.786 ± 13.645 IU/ml, respectively (mean ± s.d., 
Table 9). Those for nonsurvival group were 24.722 ± 35.371 /Amon and 35.167 ± 
37.022 IU/ml, respectively (mean ± s.d.). There was no significant differences in 
serum bile acids between survival and nonsurvival (P=0.137). There was no 
significant difference in serum y-GT concentrations between survival and 
nonsurvival group (P=0.244). Even though the horse eutrhanized for Tansy 
poisoning (No. 3), which is known to elevate both serum bile acids and y-GT 
concentration, was eliminated from the data, there were still no significant 
differences between two groups. 56 
Table 9 Liver function tests* in colic horses in survival and 
nonsaurvival group 
Survival (n=14)  Nonsurvival (n=18) 
serum bile acids (nmol/L)  10.143 ± 4.487  24.722 ± 35.371 
serum y -GT (IU/ml)  22.786 + 13.645  35.167 ± 37.022 
* Data are expressing as mean + s.d. 
Discussion 
All 32 horses had negative blood bacterial cultures, even though 9 horses 
had ischemic intestines. A horse in the ischemic group had LPS detected in plasma, 
indicating that intestinal LPS had transmigrated through the intestine without 
accompanying intact bacteria in this horse. Previous study showed no close 
relationship was observed between positive LAL assay and positive blood cultures 
in human subjects with septic shock.m There was no relationship in the prognosis 
of colic and level of endotoxin in the plasma. Only one out of 9 horses in ischemic 
group (No.28) had LPS detected in plasma, and a horse with peritonitis (No. 1) 
had 48.18 pg/ml of LPS detected in the plasma, however both survived. This 
finding was inconsistent with previous results reported by Henry and Moore in 
which colic horses with plasma LPS concentrations greater than 10.0 pg/ml did not 
survive, and that LPS was most commonly detected in plasma of colic horses with 
ischemic intestine requiring resection.97 However, the authors failed to mention the 
detailed procedures for preparing positive and negative controls. Fessler et al. 
studied plasma LPS concentrations by use of LPS reconstituted control standards in 57 
equine plasma in the 37 horses with spontaneously occurring disease suspected to be 
associated with septicemia and/or endotoxemia, including 8 colic cases.' 14 In the 
study, there was no close relationship between LPS concentration and the outcome of 
colic cases with endotoxemia, and the authors suggested the repeated sampling for 
LPS at control intervals with another appropriate clinicopathological parameters. 
A sufficient vascular supply and viable serosa were observed at surgery or 
necropsy findings for most of the horses in the large colon displacement group 
(n=9). Two of them were LPS-positive; 1 euthanized (No. 19) and 1 survived 
(No.20). This finding was inconsistent with previous results reported by Moore et 
al. in which endotoxin was not detected in systemic and colonic venous plasma 
during experimentally induced low-flow ischemia and repurfusion of the large 
colon. 112 No investigation has been reported that horses with non-ischemic 
intestine had LPS detected in plasma. Of the most plausible explanation is that 
there may have been some pathological changes in the mucosal function to increase 
the permeability of intestine by unknown mechanism. It is known that the horse 
contains higher amounts of enteric bacteria in the large colon than in the small 
intestine,30 however, there is no study indicating a fact of the increased 
permeability caused by large colon displacement. A previous study in the rat 
showed that increasing the gut permeability to LPS and the early appearance of 
LPS in plasma were induced by several chemicals, including D-galactosamine 
given by oral administration, and vasoactive amine given intravenously 38 Another 
possibility is that the blockage of the biliary system and subsequent leakage of LPS 58 
from biliary duct and/or portal vein to systemic circulation due to the displaced 
intestines, especially the large colon. Diver, et al. reported that several horses have 
been examined with hepatic failure, during the surgery, because of the obstruction 
of the biliary system induced by the displaced large colon.103 This phenomenon 
might contribute to 2 horses in the large colon displacement group (No. 19, 20) 
which had LPS detected in the plasma. 
The serum bile acids and y-GT are both highly specific liver function tests 
in horses,99' 
100, 103, 119  however they were not sensitive indicators in the assessment 
of prognosis of equine colic. It is known that endotoxin mediates hepatic injury,107 
however, most horses in the LPS-positive group remained in the normal range of 
these liver function tests. Therefore, it was impossible to replace liver function 
tests by the chromogenic LAL assay. No single parameters including plasma LPS, 
serum bile acids, and y-GT concentrations were useful for the determination of 
prognosis of equine colic and the status of endotoxemia. 59 
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